Massively parallel identification of functionally consequential noncoding genetic variants in undiagnosed rare...

Area of Science:

• Genomics
• Molecular Biology
• Rare Diseases

Background:

• Clinical whole genome sequencing identifies noncoding variants in rare disease patients.
• Interpreting the functional impact of noncoding variants remains a significant challenge in genetic diagnostics.

Purpose of the Study:

• To develop and validate a scalable experimental method for profiling the functional consequences of rare noncoding variants.
• To integrate functional data with genomic and clinical information for prioritizing pathogenic variants.

Main Methods:

• Utilized a massively parallel reporter assay (MPRA) to experimentally profile the regulatory activity of rare noncoding variants.
• Developed an integrative analysis combining variant functional data, genomic features, and patient clinical information.

Main Results:

• The MPRA successfully identified noncoding variants that significantly alter the regulatory capacity of genomic sequences.
• The integrative analysis prioritized candidate variants, increasing the likelihood of identifying pathogenic mutations.

Conclusions:

• This approach provides a robust framework for the functional interpretation of clinically detected noncoding variants.
• The study advances the diagnostic yield for rare disease patients with previously unexplained genetic findings.